Trademark: 78673290
Word
LENTIGEN CORPORATION
Status Date
Saturday, January 19, 2008
Filing Date
Tuesday, July 19, 2005
Published for Opposition
Tuesday, April 25, 2006
Abandoned Date
Saturday, January 19, 2008
5 Cells for medical or clinical use; Clinical medical reagents; Diagnostic preparations for clinical or medical laboratory use; Diagnostic reagents for clinical or medical laboratory use; Drug delivery agents consisting compounds that facilitate delivery of a wide range of pharmaceuticals
40 Contract manufacturing in the field of biopharmaceuticals, including lentiviral vectors
42 Development of new technology for others in the field of drug discovery and validation, gene expression and delivery, genomics research, protein and monoclonal antibody production; Medical and scientific research, namely conducting clinical trials; Pharmaceutical drug development services; Structural and functional anaylisis of genomes
Mar 25, 2008
Abandonment Notice Mailed - No Use Statement Filed
Mar 25, 2008
Abandonment - No Use Statement Filed
Jul 18, 2007
Extension 2 Granted
Jul 18, 2007
Extension 2 Filed
Jul 18, 2007
Teas Extension Received
Jul 17, 2007
Attorney Revoked And/Or Appointed
Jul 17, 2007
Teas Revoke/Appoint Attorney Received
Jan 16, 2007
Extension 1 Granted
Jan 16, 2007
Extension 1 Filed
Jan 16, 2007
Teas Extension Received
Jul 18, 2006
Noa Mailed - Sou Required From Applicant
Apr 25, 2006
Published For Opposition
Apr 5, 2006
Notice Of Publication
Mar 10, 2006
Law Office Publication Review Completed
Mar 3, 2006
Assigned To Lie
Feb 22, 2006
Approved For Pub - Principal Register
Feb 17, 2006
Examiner's Amendment Entered
Feb 17, 2006
Examiners Amendment E-Mailed
Feb 17, 2006
Examiners Amendment -Written
Feb 7, 2006
Assigned To Examiner
Jul 26, 2005
New Application Entered In Tram
Trademark Alertz updated from USPTO on 2030-01-24
